NASDAQ:BCLI

Brainstorm Cell Therapeutics Stock News

etoro logo Buy BCLI
*Your capital is at risk
$0.770
-0.0217 (-2.74%)
At Close: Jun 03, 2026
So far Monday, June 29, NASDAQ is up 3.38% and the S&P is up 2.09%. Let’s take a look at
Arizona Metals Corp. (TSX.V:AMC) (the “Company” or “Arizona Metals”) is pleased to announce that drilling at the South Zone of its Kay Mine Project, l
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 25) Brainstorm Cell...
Maxim Group analyst Jason McCarthy assigned a Buy rating to Titan Pharmaceuticals (TTNP – Research Report) today and set a
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Soligenix (SNGX – Research Report),
The following is a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) * ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24) ACADIA...
BrainStorm Cell Therapeutics Inc said on Wednesday it will begin a clinical trial of its experimental stem cell treatment in patients with Alzheimer's disease. The U.S.-Israeli company is already con

Reuters Health News Summary

01:00pm, Wednesday, 24'th Jun 2020
There were 2,531 new coronavirus infections reported in the past 24 hours, raising the total number of cases to 212,501, along with 9,996 deaths in all, the ministry said on Wednesday.
BrainStorm Cell Therapeutics Inc said on Wednesday it will begin a clinical trial of its experimental stem cell treatment in patients with Alzheimer's disease.
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced a new clinical program focused on the development of
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medic
In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on BioNano Genomics (BNGO – Research
BrainStorm Cell Therapeutics Inc. (NasdaqCM: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that its shares will join the Russell 2000® Index
Maxim Group analyst Jason McCarthy assigned a Buy rating to Heat Biologics (HTBX – Research Report) today and set a
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE